All Stories

  1. Effects of Gestational Exercise on Nociception, BDNF, and Irisin Levels in an Animal Model of ADHD
  2. Effects of sex and gestational exercise on pain perception, BDNF and irisin levels in an animal model of ADHD
  3. Defective proteostasis in Alzheimer’s disease
  4. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
  5. AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models
  6. Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression
  7. Lung inflammation induced by silica particles triggers hippocampal inflammation, synapse damage and memory impairment in mice
  8. Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia
  9. Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans
  10. Biomarkers for dementia in Latin American countries: Gaps and opportunities
  11. Irisin stimulates protective signaling pathways in rat hippocampal neurons
  12. Uncovering bidirectional brain-body interactions in health and disease
  13. The unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease by improving synaptic function and proteostasis
  14. AAV-mediated neuronal expression of a scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models
  15. Oxytocin attenuates microglial activation and restores social and non-social memory in the APP/PS1 mouse model of Alzheimer’s disease
  16. Inflammation at the crossroads of COVID-19, cognitive deficits and depression
  17. Impaired insulin signalling and allostatic load in Alzheimer disease
  18. Age-linked suppression of lipoxin A4 mediates cognitive deficits in mice and humans
  19. A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-β Oligomers in Mice
  20. Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer’s and Lewy Body Diseases
  21. Innate immune memory mediates increased susceptibility to Alzheimer’s disease-like pathology in sepsis surviving mice
  22. Selective Secretase Targeting for Alzheimer’s Disease Therapy
  23. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease
  24. Dementia is an age‐independent risk factor for severity and death in COVID‐19 inpatients
  25. Rapid size-exclusion high performance liquid chromatography method for the quality control of amyloid-β oligomers
  26. Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer’s disease
  27. Interleukin-1β mediates alterations in mitochondrial fusion/fission proteins and memory impairment induced by amyloid-β oligomers
  28. Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer’s disease
  29. Dementia in Latin America: Paving the way toward a regional action plan
  30. Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity and memory in mouse models of Alzheimer’s disease
  31. Erratum: Forny-Germano et al., “Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates”
  32. Correction: Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
  33. Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer’s diseases
  34. The aroylhydrazone INHHQ prevents memory impairment induced by Alzheimer’s-linked amyloid-β oligomers in mice
  35. Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease
  36. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
  37. Amyloid‐β oligomers in cellular models of Alzheimer’s disease
  38. Amyloid-β Fosters p35/CDK5 Signaling Contributing to Changes of Inhibitory Synapses in Early Stages of Cerebral Amyloidosis
  39. Morphometric Analysis of Hippocampal and Neocortical Pyramidal Neurons in a Mouse Model of Late Onset Alzheimer’s Disease
  40. Modulation in phase and frequency of neural oscillations during epileptiform activity induced by neonatal Zika virus infection in mice
  41. Palmitate Is Increased in the Cerebrospinal Fluid of Humans with Obesity and Induces Memory Impairment in Mice via Pro-inflammatory TNF-α
  42. LDL Receptor Deficiency Does not Alter Brain Amyloid-β Levels but Causes an Exacerbation of Apoptosis
  43. Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease
  44. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model
  45. Extracellular vesicles derived from human Wharton’s jelly mesenchymal stem cells protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers
  46. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice
  47. Using a portable total reflection X‐ray fluorescence system for a multielement analysis of Swiss mice brains with experimental Alzheimer's disease induced by β‐amyloid oligomers
  48. Neonatal infection leads to increased susceptibility to Aβ oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice
  49. Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health
  50. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
  51. Mania-like elevated mood in rats: Enhanced 50-kHz ultrasonic vocalizations after sleep deprivation
  52. Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia
  53. Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases
  54. Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
  55. Free-floating adult human brain-derived slice cultures as a model to study the neuronal impact of Alzheimer’s disease-associated Aβ oligomers
  56. Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?
  57. Crosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer's disease
  58. Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
  59. Acute and chronic neurological consequences of early-life Zika virus infection in mice
  60. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
  61. Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers
  62. Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers
  63. Neonatal Zika virus infection causes epileptic seizures, viral persistence and long-term behavioral impairment
  64. A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-β oligomers
  65. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson’s disease-like symptoms in mice
  66. Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-β oligomers in mice
  67. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model
  68. Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons
  69. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice
  70. Multielement concentration analysis of Swiss mice brains on experimental model of Alzheimer's disease induced byβ-amyloid oligomers
  71. Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
  72. Diazepam Inhibits Electrically Evoked and Tonic Dopamine Release in the Nucleus Accumbens and Reverses the Effect of Amphetamine
  73. Brain-Defective Insulin Signaling Is Associated to Late Cognitive Impairment in Post-Septic Mice
  74. Getting a “GRiP” on Hypothalamic Endoplasmic Reticulum Stress to Combat Obesity
  75. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice
  76. Microglial dysfunction connects depression and Alzheimer’s disease
  77. USP46: a new piece of the memory puzzle?
  78. Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes
  79. Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
  80. d-serine levels in Alzheimer’s disease: implications for novel biomarker development
  81. Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease
  82. Alzheimer-associated A  oligomers impact the central nervous system to induce peripheral metabolic deregulation
  83. Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates
  84. Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
  85. Accumulation of Intraneuronal Amyloid-β is Common in Normal Brain
  86. How does brain insulin resistance develop in Alzheimer's disease?
  87. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
  88. TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer’s β-Amyloid Oligomers in Mice and Monkeys
  89. 2,4-dinitrophenol induces neural differentiation of murine embryonic stem cells
  90. The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity
  91. Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis
  92. Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons
  93. Rescue of Amyloid-Beta-Induced Inhibition of Nicotinic Acetylcholine Receptors by a Peptide Homologous to the Nicotine Binding Domain of the Alpha 7 Subtype
  94. α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death.
  95. Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight A  Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers
  96. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease
  97. Plasma levels of D-serine in Brazilian individuals with schizophrenia
  98. Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
  99. Human Apolipoprotein A-I Natural Variants: Molecular Mechanisms Underlying Amyloidogenic Propensity
  100. Inhibition of Choline Acetyltransferase as a Mechanism for Cholinergic Dysfunction Induced by Amyloid-β Peptide Oligomers
  101. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
  102. Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices
  103. α-Secretase-derived Fragment of Cellular Prion, N1, Protects against Monomeric and Oligomeric Amyloid β (Aβ)-associated Cell Death
  104. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
  105. Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons
  106. Human Apolipoprotein A-I-Derived Amyloid: Its Association with Atherosclerosis
  107. Amyloid β-Peptide Oligomers Stimulate RyR-Mediated Ca2+ Release Inducing Mitochondrial Fragmentation in Hippocampal Neurons and Prevent RyR-Mediated Dendritic Spine Remodeling Produced by BDNF
  108. Amyloid-beta oligomers increase the localization of prion protein at the cell surface
  109. Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers
  110. Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria
  111. Protein kinase C activity regulates d-serine availability in the brain
  112. N‐Methyl‐d‐aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid‐β peptide oligomers
  113. Amyloid-β Decreases Nitric Oxide Production in Cultured Retinal Neurons: A Possible Mechanism for Synaptic Dysfunction in Alzheimer’s Disease?
  114. Amyloid-  Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3  in Primary Cultured Hippocampal Neurons
  115. 2,4-Dinitrophenol Blocks Neurodegeneration and Preserves Sciatic Nerve Function after Trauma
  116. Expression Profile of Rat Hippocampal Neurons Treated with the Neuroprotective Compound 2,4-Dinitrophenol: Up-Regulation of cAMP Signaling Genes
  117. Conformational plasticity of DM43, a metalloproteinase inhibitor from Didelphis marsupialis: Chemical and pressure-induced equilibrium (un)folding studies
  118. Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer’s Disease
  119. Human apolipoprotein A–I binds amyloid-β and prevents Aβ-induced neurotoxicity
  120. Correction for De Felice et al., Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
  121. Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
  122. Reductive inactivation of yeast glutathione reductase by Fe(II) and NADPH
  123. Amyloid-β Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/β-Catenin Signaling
  124. Interrogating global gene expression in rat neuronal cultures using SAGE
  125. Soluble oligomers from a non‐disease related protein mimic Aβ‐induced tau hyperphosphorylation and neurodegeneration
  126. Cyclic AMP Enhancers and Aβ Oligomerization Blockers as Potential Therapeutic Agents in Alzheimers Disease
  127. Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts
  128. Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine
  129. Whither Latin America? trends and challenges of science in Latin America
  130. Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases
  131. Quantitative histogram analysis of images
  132. Long-Lived Conformational Isomerism of Protein Dimers: The Role of the Free Energy of Subunit Association
  133. Formation of Soluble Oligomers and Amyloid Fibrils with Physical Properties of the Scrapie Isoform of the Prion Protein from the C-terminal Domain of Recombinant Murine Prion Protein mPrP-(121–231)
  134. Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of 2,4-dinitrophenol: The gentle face of Janus
  135. Solution Conformation and Heparin-induced Dimerization of the Full-length Extracellular Domain of the Human Amyloid Precursor Protein
  136. Metastable, Partially Folded States in the Productive Folding and in the Misfolding and Amyloid Aggregation of Proteins
  137. Small Molecule Inhibitors of Lysozyme Amyloid Aggregation
  138. Activation of GABAA receptors by taurine and muscimol blocks the neurotoxicity of β-amyloid in rat hippocampal and cortical neurons
  139. Structural and morphological characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus
  140. Neuritogenesis and neuronal differentiation promoted by 2,4‐dinitrophenol, a novel anti‐amyloidogenic compound
  141. Acid- and pressure-induced (un)folding of yeast glutathione reductase: Competition between protein oligomerization and aggregation
  142. Heparin-binding Sites in Granulocyte-Macrophage Colony-stimulating Factor
  143. Peptide Blockers of the Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Amyloid β
  144. Folding and stability of a coiled-coil investigated using chemical and physical denaturing agents: Comparative analysis of polymerized and non-polymerized forms of α-tropomyosin
  145. Protein Folding, Misfolding and Aggregation: Evolving Concepts and Conformational Diseases
  146. Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP)
  147. Biological evaluation of a protein isolate from cowpea (Vigna unguiculata) seeds
  148. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization
  149. Inhibition of Heme Aggregation by Chloroquine ReducesSchistosoma mansoniInfection
  150. Formation of amyloid aggregates from human lysozyme and its disease‐associated variants using hydrostatic pressure
  151. Inhibition of yeast glutathione reductase by trehalose: possible implications in yeast survival and recovery from stress
  152. Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders
  153. Redesigning the Folding Energetics of a Model Three-helix Bundle Protein by Site-directed Mutagenesis
  154. Closed Conformation of the Active Site Loop of Rabbit Muscle Triosephosphate Isomerase in the Absence of Substrate: Evidence of Conformational Heterogeneity
  155. Folding Intermediates of the Prion Protein Stabilized by Hydrostatic Pressure and Low Temperature
  156. Persistent Conformational Heterogeneity of Triosephosphate Isomerase:  Separation and Characterization of Conformational Isomers in Solution
  157. Folding and Stability of the Extracellular Domain of the Human Amyloid Precursor Protein
  158. Functional Properties of Purified Vicilins from Cowpea (Vigna unguiculata) and Pea (Pisum sativum) and Cowpea Protein Isolate
  159. Neuroprotection against Aβ and glutamate toxicity by melatonin: Are GABA receptors involved?
  160. Equilibrium unfolding and conformational plasticity of troponin I and T
  161. Folding of a de Novo Designed Native-like Four-helix Bundle Protein
  162. Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseases
  163. Dimethylsulfoxide promotes K+‐independent activity of pyruvate kinase and the acquisition of the active catalytic conformation
  164. Iron-induced oxidative damage of corn root plasma membrane H+-ATPase
  165. Dual role of glutamatergic neurotransmission on amyloid β1–42 aggregation and neurotoxicity in embryonic avian retina
  166. Crystal structures of bovine beta-lactoglobulin in the orthorhombic space group C2221 . Structural differences between genetic variants A and B and features of the Tanford transition
  167. Folding Intermediates of a Model Three-helix Bundle Protein
  168. Haemozoin in Schistosoma mansoni
  169. Preliminary X-ray diffraction studies of rabbit muscle triose phosphate isomerase (TIM)
  170. Inhibition of the Ecto-ATPdiphosphohydrolase of Schistosoma mansoni by Thapsigargin
  171. Selective Neoglycosylation Increases the Structural Stability of Vicilin, the 7S Storage Globulin from Pea Seeds
  172. Pressure denaturation of β‐lactoglobulin
  173. Subunit dissociation and inactivation of pyruvate kinase by hydrostatic pressure
  174. Acidic pH Modulates the Interaction between Human Granulocyte-Macrophage Colony-stimulating Factor and Glycosaminoglycans
  175. Oxidative damage to sarcoplasmic reticulum Ca2+-ATPase at submicromolar iron concentrations: evidence for metal-catalyzed oxidation
  176. International Symposium on Protein Condensation, in Honor of Gregorio Weber, May 21–25, 1997, Rio de Janeiro, Brazil
  177. Divalent cation dependence and inhibition of Schistosoma mansoni ATP diphosphohydrolase by fluorosulfonylbenzoyl adenosine
  178. Kinetics and Energetics of Subunit Dissociation/Unfolding of TIM:  The Importance of Oligomerization for Conformational Persistence and Chemical Stability of Proteins
  179. Role of Phospholipids in the Protein Stability of an Insect Lipoprotein, Lipophorin from Rhodnius prolixus
  180. Partial Purification and Immunohistochemical Localization of ATP Diphosphohydrolase from Schistosoma mansoni
  181. Deterministic Pressure Dissociation and Unfolding of Triose Phosphate Isomerase:  Persistent Heterogeneity of a Protein Dimer
  182. Oxidative damage to sarcoplasmic reticulum Ca2+-pump induced by Fe2+/H2O2/ascorbate is not mediated by lipid peroxidation or thiol oxidation and leads to protein fragmentation
  183. Refolding of Triosephosphate Isomerase in Low-Water Media Investigated by Fluorescence Resonance Energy Transfer
  184. Inter-Active-Site Distance and Solution Dynamics of a Bivalent-Bispecific Single-Chain Antibody Molecule
  185. Anisotropic Rotational Diffusion of the Adenine Moiety in 1,N6-Ethenoadenosine Triphosphate in Viscous Solvents Investigated by Time-Resolved Fluorescence Spectroscopy
  186. Betaine counteracts urea‐induced conformational changes and uncoupling of the human erythrocyte Ca2+ pump
  187. Deterministic Pressure-Induced Dissociation of Vicilin, the 7S Storage Globulin from Pea Seeds: Effects of pH and Cosolvents on Oligomer Stability
  188. FLUORESCENCE LIFETIME AND QUENCHING STUDIES OF SARCOPLASMIC RETICULUM CA2+ ‐ADENOSINE‐5′‐TRIPHOSPHATASE*
  189. Characterization and localization of an ATP-diphosphohydrolase on the external surface of the tegument of Schistosoma mansoni
  190. Time-resolved fluorescence of erythrocyte plasma membrane ca2+-atpase in different functional states
  191. Global analysis of wavelength-resolved fluorescence decay in sarcoplasmic reticulum calcium - ATPase
  192. Hydration and protein substates: Fluorescence of proteins in reverse micelles
  193. Fluorescence studies of the conformational dynamics of parvalbumin in solution: lifetime and rotational motions of the single tryptophan residue
  194. Probing the Nucleotide Binding Sites of Sarcoplasmic Reticulum Atpase by Photoaffinity Labeling